235 related articles for article (PubMed ID: 23869245)
1. Activation of Wnt/β-catenin signaling increases apoptosis in melanoma cells treated with trail.
Zimmerman ZF; Kulikauskas RM; Bomsztyk K; Moon RT; Chien AJ
PLoS One; 2013; 8(7):e69593. PubMed ID: 23869245
[TBL] [Abstract][Full Text] [Related]
2. Regulating the response to targeted MEK inhibition in melanoma: enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation.
Conrad WH; Swift RD; Biechele TL; Kulikauskas RM; Moon RT; Chien AJ
Cell Cycle; 2012 Oct; 11(20):3724-30. PubMed ID: 22895053
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells.
Park JH; Kwon HY; Sohn EJ; Kim KA; Kim B; Jeong SJ; Song JH; Koo JS; Kim SH
Pharmacol Rep; 2013; 65(5):1366-74. PubMed ID: 24399733
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma.
Biechele TL; Kulikauskas RM; Toroni RA; Lucero OM; Swift RD; James RG; Robin NC; Dawson DW; Moon RT; Chien AJ
Sci Signal; 2012 Jan; 5(206):ra3. PubMed ID: 22234612
[TBL] [Abstract][Full Text] [Related]
5. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells.
Gillespie S; Borrow J; Zhang XD; Hersey P
Apoptosis; 2006 Dec; 11(12):2251-65. PubMed ID: 17051334
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase PKN1 represses Wnt/β-catenin signaling in human melanoma cells.
James RG; Bosch KA; Kulikauskas RM; Yang PT; Robin NC; Toroni RA; Biechele TL; Berndt JD; von Haller PD; Eng JK; Wolf-Yadlin A; Chien AJ; Moon RT
J Biol Chem; 2013 Nov; 288(48):34658-70. PubMed ID: 24114839
[TBL] [Abstract][Full Text] [Related]
7. Mcl-1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells.
Sarif Z; Tolksdorf B; Fechner H; Eberle J
Mol Carcinog; 2020 Nov; 59(11):1256-1268. PubMed ID: 32885857
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins.
Werneburg NW; Guicciardi ME; Bronk SF; Kaufmann SH; Gores GJ
J Biol Chem; 2007 Sep; 282(39):28960-28970. PubMed ID: 17686764
[TBL] [Abstract][Full Text] [Related]
9. RAF inhibition overcomes resistance to TRAIL-induced apoptosis in melanoma cells.
Berger A; Quast SA; Plötz M; Kuhn NF; Trefzer U; Eberle J
J Invest Dermatol; 2014 Feb; 134(2):430-440. PubMed ID: 23955071
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3 inhibition sensitizes pancreatic cancer cells to TRAIL-induced apoptosis.
Mamaghani S; Simpson CD; Cao PM; Cheung M; Chow S; Bandarchi B; Schimmer AD; Hedley DW
PLoS One; 2012; 7(7):e41102. PubMed ID: 22829912
[TBL] [Abstract][Full Text] [Related]
11. Axin1 up-regulated 1 accelerates stress-induced cardiomyocytes apoptosis through activating Wnt/β-catenin signaling.
Ye X; Lin J; Lin Z; Xue A; Li L; Zhao Z; Liu L; Shen Y; Cong B
Exp Cell Res; 2017 Oct; 359(2):441-448. PubMed ID: 28830684
[TBL] [Abstract][Full Text] [Related]
12. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
13. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
14. Caspase-mediated cleavage of beta-catenin precedes drug-induced apoptosis in resistant cancer cells.
Senthivinayagam S; Mishra P; Paramasivam SK; Yallapragada S; Chatterjee M; Wong L; Rana A; Rana B
J Biol Chem; 2009 May; 284(20):13577-13588. PubMed ID: 19289465
[TBL] [Abstract][Full Text] [Related]
15. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.
Almeida M; Han L; Bellido T; Manolagas SC; Kousteni S
J Biol Chem; 2005 Dec; 280(50):41342-51. PubMed ID: 16251184
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.
Orme MH; Giannini AL; Vivanco MD; Kypta RM
Mol Cell Neurosci; 2003 Nov; 24(3):673-86. PubMed ID: 14664817
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin and MAPK signaling: allies and enemies in different battlefields.
Guardavaccaro D; Clevers H
Sci Signal; 2012 Apr; 5(219):pe15. PubMed ID: 22494969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]